Major Estimate Revision • May 01
Consensus revenue estimates fall by 33% The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from AU$30.0m to AU$20.0m. Forecast losses increased from -AU$0.006 to -AU$0.016 per share. Chemicals industry in Australia expected to see average net income growth of 54% next year. Consensus price target of AU$0.50 unchanged from last update. Share price fell 3.6% to AU$0.27 over the past week. New Risk • Apr 30
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: AU$36m Forecast net loss in 2 years: AU$2.0m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-AU$47m). Currently unprofitable and not forecast to become profitable over next 2 years (AU$2.0m net loss in 2 years). Shareholders have been diluted in the past year (21% increase in shares outstanding). Significant insider selling over the past 3 months (AU$653k sold). Buy Or Sell Opportunity • Apr 24
Now 22% undervalued Over the last 90 days, the stock has risen 12% to AU$0.28. The fair value is estimated to be AU$0.36, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 80%. Revenue is forecast to grow by 526% in 2 years. Earnings are forecast to grow by 60% in the next 2 years. Recent Insider Transactions • Apr 11
Independent Non-Executive Director recently sold AU$551k worth of stock On the 7th of April, Mira Ricardel sold around 2m shares on-market at roughly AU$0.32 per share. This transaction amounted to 89% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of AU$653k more than they bought in the last 12 months. New Risk • Mar 19
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: AU$101k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Shareholders have been diluted in the past year (21% increase in shares outstanding). Significant insider selling over the past 3 months (AU$101k sold). New Risk • Mar 15
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Shareholders have been diluted in the past year (21% increase in shares outstanding). Major Estimate Revision • Mar 14
Consensus revenue estimates increase by 50% The consensus outlook for revenues in fiscal year 2026 has improved. 2026 revenue forecast increased from AU$20.0m to AU$30.0m. Forecast losses expected to reduce from -AU$0.016 to -AU$0.006 per share. Chemicals industry in Australia expected to see average net income growth of 54% next year. Consensus price target of AU$0.40 unchanged from last update. Share price fell 2.3% to AU$0.21 over the past week. Ankündigung • Mar 14
Titomic Limited Appoints Lieutenant General (Retired) Henry “Trey” Obering as Independent Non-Executive Director, Effective March 11, 2026 Titomic Limited announces the appointment of retired Lt Gen Henry “Trey” Obering as an Independent Non-Executive Director of the Company, effective March 11, 2026. Lt Gen Obering brings extensive experience in missile defense systems, space architectures, and the acquisition of complex national security capabilities. Lt Gen Obering retired from the United States Air Force with more than 35 years of distinguished service, including serving as Director of the U.S. Missile Defense Agency (MDA), where he led the development, testing, and fielding of the nation’s Ballistic Missile Defense System. As Director, he was the Department of Defense Acquisition Executive responsible for the United States’ $10 billion annual missile defense portfolio and oversaw an organization of more than 8,500 personnel supporting critical national defense capabilities. Prior to his leadership at MDA, Lt Gen Obering served as Mission Area Director for Information Dominance on the Air Staff, where he planned and programmed 68 joint, Air Force, and international programs with a combined budget of approximately $28 billion. Following his military career, Lt Gen Obering joined Booz Allen Hamilton, where he served as Executive Vice President based in Herndon, Virginia. In this role he advised senior defense and intelligence community leaders on acquisition strategy, advanced technologies, and national security programs. He also led the firm’s Acquisition Program Management and Logistics Functional Community, supporting the development of hundreds of acquisition professionals across the organization. Lt Gen Obering also led a comprehensive review of the National Reconnaissance Office (NRO) for the Director of National Intelligence, helping establish a new charter and organizational framework for the agency. Lt Gen Obering entered the Air Force in 1973 after graduating from the University of Notre Dame’s ROTC program as a distinguished graduate. He received his pilot wings in 1975 and flew operational assignments in the F-4E Phantom II. Later, he served in the NASA Space Shuttle program, participating in 15 space shuttle launches as a NASA orbiter project engineer responsible for integrating firing room launch operations. Other assignments during his career included tours with the Air Force Inspector General, the Defense Mapping Agency, and the Electronic Systems Center. Lt Gen Obering has twice been awarded the Department of Defense’s highest non-combat award, the Defense Distinguished Service Medal, for exceptional leadership. He was also honored by the National Defense Industrial Association’s Missile Defense Division with the 2011 Kadish Award for Acquisition Excellence. He holds a Bachelor of Science in Aerospace Engineering from the University of Notre Dame and a Master of Science in Astronautical Engineering from Stanford University. Lt Gen Obering has served on Titomic’s U.S. Strategic Advisory Board since January 2025 and will continue to support the Company’s advisory activities in addition to his role as a Non-Executive Director. Major Estimate Revision • Mar 03
Consensus revenue estimates decrease by 20%, EPS upgraded The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from AU$25.0m to AU$20.0m. EPS estimate increased from -AU$0.0055 to -AU$0.002 per share. Chemicals industry in Australia expected to see average net income growth of 54% next year. Consensus price target of AU$0.40 unchanged from last update. Share price rose 13% to AU$0.22 over the past week. Recent Insider Transactions • Feb 16
CEO, MD & Director recently sold AU$101k worth of stock On the 13th of February, Jim Simpson sold around 472k shares on-market at roughly AU$0.21 per share. This transaction amounted to 7.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Jim's only on-market trade for the last 12 months. Ankündigung • Jan 27
Titomic Limited Appoints Jim Chilton to Strategic Advisory Group Titomic Limited announced the appointment of Jim Chilton to its Strategic Advisory Group (SAG). Mr. Chilton brings nearly four decades of experience from Boeing, where he most recently served as Senior Vice President and Senior Advisor to Boeing Defense, Space & Security. In this role, he provided strategic counsel across some of the most complex and high-profile programs in the global aerospace and defense sector. Previously, Mr. Chilton was Senior Vice President of Boeing Defense’s Space & Launch division, overseeing a broad portfolio including the International Space Station, NASA’s Space Launch System (SLS), the CST-100 Starliner commercial crew vehicle, government and commercial satellite systems, and Boeing’s participation in United Launch Alliance. He also served as President Network & Space Systems, including missile defense, weapons and intelligence portfolios. Mr. Chilton is a member of the International Academy of Astronautics and serves on its Board of Trustees, Engineering Sciences Section. He has also contributed to the International Astronautical Federation and various non-profit boards. He holds a Bachelor of Mechanical Engineering from Washington State University, a master’s degree from the Florida Institute of Technology, and is a graduate of Harvard Business School’s Advanced Management Program. Ankündigung • Jan 06
Titomic Limited Announces Management Changes Titomic Limited announced a series of strategic leadership changes within its European division designed to strengthen operational execution, accelerate growth, and support the company’s global expansion. As part of a structured transition plan, Chris Myers will assume the role of President, Titomic Europe effective January 1, 2026, succeeding Klaas Rozema, who will transition into the role of Senior Executive Advisor before commencing a planned sabbatical in March 2026. Chris Myers, who has served as part of Titomic’s Senior Advisory Group and Consultant since its inception in January 2025, brings deep experience in advanced manufacturing, aerospace, and defense programs and has been actively transitioning into the leadership role through a structured knowledge-transfer and customer engagement program underway since October 2025. He will assume full executive responsibility on 1 February 2026. Also, as part of the transition, Ferdy Touwen has been promoted to Deputy President & Head of European Operations, taking responsibility for day-to-day operational leadership, production, quality, logistics, and HR functions. Ferdy will serve as the operational lead under Chris and plays a key role in driving efficiency, delivery performance, and execution excellence across the European business. Klaas Rozema has been central to integrating Titomic’s technology with Dycomet’s legacy of innovation, expanding the company’s European footprint, supporting the launch of Titomic’s new facilities, and contributing to global Cold Spray adoption. Ankündigung • Dec 19
Titomic Limited has completed a Follow-on Equity Offering in the amount of AUD 50.35 million. Titomic Limited has completed a Follow-on Equity Offering in the amount of AUD 50.35 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 200,000,000
Price\Range: AUD 0.25
Discount Per Security: AUD 0.01375
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,400,000
Price\Range: AUD 0.25
Discount Per Security: AUD 0.01375
Transaction Features: Subsequent Direct Listing Ankündigung • Oct 24
Titomic Limited, Annual General Meeting, Nov 25, 2025 Titomic Limited, Annual General Meeting, Nov 25, 2025. Ankündigung • Sep 26
Titomic Limited Appoints Aude Vignelles as President of Asia-Pacific Region Titomic Limited announced the appointment of Aude Vignelles as President of the Asia-Pacific Region (APAC), based in Melbourne. Ms. Vignelles brings an exceptional track record in aerospace, space, telecommunications, and advanced technology sectors, further strengthening Titomic's executive leadership during a pivotal period of regional growth and transformation. Aude Vignelles is the former Chief Technology Officer of the Australian Space Agency, where she led the development of Australia's Civil Space Strategy Technical Roadmaps, scoped and managed the Agency's national programs, and delivered international engagements across the space ecosystem. Her leadership played a crucial role in shaping the direction of Australia's civil space capabilities and fostering global partnerships. Ms. Vignelles began her career at the European Space Agency (ESA) in the Netherlands, supporting scientific missions including Rosetta and later serving as Test Manager for the X-ray Multi-Mirror Mission (XMM)—the scientific space program ever undertaken by ESA at the time. She then held executive roles in the broadcast and telecommunications sectors, including leadership at ONdigital, Foxtel, Austar, and as Vice President of Technicolor APAC. Prior to joining Titomic, she also served as Executive Manager of Satellite & Fixed Wireless Operations at nbn, Australia's national broadband network provider. Her background in engineering, program delivery, and public-private sector engagement positions her uniquely to drive Titomic's mission in the region. Titomic is currently expanding its Australian operations as part of a broader transformation, including increased investments in defense and aerospace through partnerships with industry leaders, new business development strategies, and operational enhancements driven by internal promotion and external advisory support. Major Estimate Revision • Sep 03
Consensus EPS estimates fall by 50% The consensus outlook for fiscal year 2026 has been updated. 2026 expected loss increased from -AU$0.006 to -AU$0.009 per share. Revenue forecast of AU$25.0m unchanged since last update. Chemicals industry in Australia expected to see average net income growth of 11% next year. Consensus price target of AU$0.40 unchanged from last update. Share price rose 8.7% to AU$0.25 over the past week. Reported Earnings • Aug 29
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: AU$0. Revenue: AU$9.43m (up 23% from FY 2024). Net loss: AU$19.9m (loss widened 67% from FY 2024). Revenue missed analyst estimates by 17%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Australia. Ankündigung • Jul 25
Titomic Limited has filed a Follow-on Equity Offering in the amount of AUD 50.35 million. Titomic Limited has filed a Follow-on Equity Offering in the amount of AUD 50.35 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 200,000,000
Price\Range: AUD 0.25
Discount Per Security: AUD 0.01375
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,400,000
Price\Range: AUD 0.25
Discount Per Security: AUD 0.01375
Transaction Features: Subsequent Direct Listing New Risk • Jul 07
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: AU$13m Forecast net loss in 3 years: AU$447k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$447k net loss in 3 years). Revenue is less than US$5m (AU$7.4m revenue, or US$4.8m). Breakeven Date Change • Jun 30
Forecast to breakeven in 2028 The analyst covering Titomic expects the company to break even for the first time. New forecast suggests the company will make a profit of AU$8.20m in 2028. Average annual earnings growth of 77% is required to achieve expected profit on schedule. Major Estimate Revision • Apr 16
Consensus EPS estimates fall by 9,801% The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -AU$0.012 to -AU$1.20 per share. Revenue forecast unchanged at AU$8.50m. Chemicals industry in Australia expected to see average net income growth of 11% next year. Consensus price target of AU$0.30 unchanged from last update. Share price rose 38% to AU$0.23 over the past week. Ankündigung • Apr 08
Titomic Limited Announces Appointment of Kirk Pysher as Senior Vice President of U.S. Manufacturing and Production At Titomic USA, Inc Titomic Limited announced the appointment of Kirk Pysher as Senior Vice President (SVP) of U.S. Manufacturing and Production at Titomic USA Inc. In this key executive role, Kirk will be responsible for establishing, scaling, and optimizing Titomic's U.S. manufacturing and production capabilities. Based in Huntsville, Alabama, he will spearhead the development and execution of the company's advanced manufacturing operations, including Cold Spray Kinetic Fusion additive manufacturing, and coating and repair services. These capabilities are critical to Titomic's core market sectors--aerospace, defense, energy, infrastructure, and research institutions. Kirk brings a distinguished track record in aerospace and launch systems. Before joining Titomic, he most recently served as Vice President of Mission Assurance, Quality, and Safety at Virgin Orbit, where he played a key role in advancing mission-critical systems and organizational excellence. Prior to that, he served as President of International Launch Services (ILS), where he led transformative upgrades to the Proton rocket launcher, including the introduction of automation on its assembly line. He has also held leadership roles at Sea Launch, where he served as both Chief Operating Officer and Chief Engineer. New Risk • Feb 28
New major risk - Revenue and earnings growth Earnings have declined by 8.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 8.9% per year over the past 5 years. Shareholders have been substantially diluted in the past year (45% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (AU$7.7m revenue, or US$4.8m). New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 40% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (40% increase in shares outstanding). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$700k net loss in 3 years). Share price has been volatile over the past 3 months (16% average weekly change). Revenue is less than US$5m (AU$7.7m revenue, or US$4.8m). Ankündigung • Dec 20
Titomic Limited Announces Executive Changes Titomic Limited announced the appointment of Mr. Geoff Hollis as joint company secretary, effective December 20, 2024. Mr. Hollis commenced as chief financial officer of the company in May 2024 and has over 14 years' experience as a company secretary of ASX listed companies. Mr. Christopher Healy, the company's current company secretary has informed Titomic of his resignation effective 31 January 2025. Mr. Healy will cease in his role as company Secretary on that date and Mr. Hollis will assume sole responsibility. Board Change • Dec 09
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Non-Executive Director Mira Ricardel was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Oct 31
Titomic Limited, Annual General Meeting, Nov 29, 2024 Titomic Limited, Annual General Meeting, Nov 29, 2024. Location: 365 ferntree gully road, mount waverley, victoria 3149, Australia Ankündigung • Oct 18
Titomic Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million. Titomic Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 143,211,735
Price\Range: AUD 0.12
Discount Per Security: AUD 0.0072
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 106,788,265
Price\Range: AUD 0.12
Discount Per Security: AUD 0.0072
Transaction Features: Subsequent Direct Listing Ankündigung • Sep 26
United Industrial Solutions agreed to acquire Titomic D623 cold spray system from Titomic Limited (ASX:TTT) for AUD 0.17 million. United Industrial Solutions agreed to acquire Titomic D623 cold spray system from Titomic Limited (ASX:TTT) for AUD 0.17 million on September 26, 2024. A cash consideration of AUD 0.17 million will be paid by United Industrial Solutions. As part of consideration, AUD 0.17 million is paid towards assets of Titomic D623 cold spray system. New Risk • Sep 03
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$7.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$7.1m free cash flow). Share price has been highly volatile over the past 3 months (20% average weekly change). Earnings have declined by 8.8% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (18% increase in shares outstanding). Reported Earnings • Sep 03
Full year 2024 earnings released: EPS: AU$0 (vs AU$0.07 loss in FY 2023) Full year 2024 results: EPS: AU$0 (improved from AU$0.07 loss in FY 2023). Revenue: AU$7.70m (up 72% from FY 2023). Net loss: AU$11.9m (loss narrowed 22% from FY 2023). Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Ankündigung • Aug 28
Titomic Limited to Report Fiscal Year 2024 Results on Aug 30, 2024 Titomic Limited announced that they will report fiscal year 2024 results on Aug 30, 2024 New Risk • Jun 08
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 16% per year over the past 5 years. Shareholders have been substantially diluted in the past year (323% increase in shares outstanding). Minor Risks Revenue is less than US$5m (AU$5.9m revenue, or US$3.9m). Market cap is less than US$100m (AU$92.0m market cap, or US$60.5m). Ankündigung • May 03
Titomic Limited has completed a Follow-on Equity Offering in the amount of AUD 4.5 million. Titomic Limited has completed a Follow-on Equity Offering in the amount of AUD 4.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 90,000,000
Price\Range: AUD 0.05
Discount Per Security: AUD 0.002
Transaction Features: Subsequent Direct Listing Ankündigung • Apr 25
Titomic Limited has filed a Follow-on Equity Offering in the amount of AUD 4.5 million. Titomic Limited has filed a Follow-on Equity Offering in the amount of AUD 4.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 90,000,000
Price\Range: AUD 0.05
Discount Per Security: AUD 0.002
Transaction Features: Subsequent Direct Listing Reported Earnings • Mar 06
First half 2024 earnings released First half 2024 results: Revenue: AU$4.21m (up 51% from 1H 2023). Net loss: AU$5.90m (loss narrowed 19% from 1H 2023). New Risk • Mar 02
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$8.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$8.3m free cash flow). Earnings have declined by 16% per year over the past 5 years. Shareholders have been substantially diluted in the past year (285% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Revenue is less than US$5m (AU$5.9m revenue, or US$3.9m). Market cap is less than US$100m (AU$28.3m market cap, or US$18.5m). Ankündigung • Feb 28
Titomic Limited to Report First Half, 2024 Results on Feb 29, 2024 Titomic Limited announced that they will report first half, 2024 results on Feb 29, 2024 Ankündigung • Dec 06
Titomic Limited has completed a Follow-on Equity Offering in the amount of AUD 1 million. Titomic Limited has completed a Follow-on Equity Offering in the amount of AUD 1 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 75,000,000
Price\Range: AUD 0.01
Discount Per Security: AUD 0.0006
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 25,000,000
Price\Range: AUD 0.01
Discount Per Security: AUD 0.0006
Transaction Features: Subsequent Direct Listing Ankündigung • Oct 20
Titomic Limited, Annual General Meeting, Nov 23, 2023 Titomic Limited, Annual General Meeting, Nov 23, 2023, at 11:01 AUS Eastern Standard Time. Location: 365 Ferntree Gully Road, Mount Waverley, Victoria 3149 Victoria Australia Agenda: To discuss 2023 Annual Financial Statements; to discuss Adoption of 2023 Remuneration Report; to discuss Re-election of Mr Humphrey Nolan; to discuss Re-election of Mr Dag W.R. Stromme; to discuss Ratification of prior issue of Placement Shares to investors; to discuss Approval of issue of Placement Shares to Mr Dag W.R. Stromme; to discuss Approval of issue of share rights and Options to the Directors of the Company; to discuss Approval of issue of Shares to Mr Herbert Koeck; and to discuss Approval of additional capacity to issue securities under ASX Listing Rule 7.1A. New Risk • Oct 05
New major risk - Negative shareholders equity The company has negative equity. Total equity: -AU$715k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$12m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Negative equity (-AU$715k). Earnings have declined by 23% per year over the past 5 years. Shareholders have been substantially diluted in the past year (321% increase in shares outstanding). Market cap is less than US$10m (AU$12.1m market cap, or US$7.68m). Minor Risk Revenue is less than US$5m (AU$4.5m revenue, or US$2.8m). Reported Earnings • Oct 05
Full year 2023 earnings released: AU$0.07 loss per share (vs AU$0.09 loss in FY 2022) Full year 2023 results: AU$0.07 loss per share (improved from AU$0.09 loss in FY 2022). Revenue: AU$4.49m (down 16% from FY 2022). Net loss: AU$15.3m (loss narrowed 9.7% from FY 2022). Ankündigung • Oct 05
Titomic Limited Announces Board Changes Titomic Limited announced that director Mr. Dag W.R. Stromme has assumed the role of Chair of the Board, effective 2nd October, 2023. Titomic's Managing Director, Mr. Herbert Koeck, will relocate to Europe before the end of the year in order to be closer to the Company's key markets including Europe and North America. With this being the case, the Board has determined it is appropriate that Mr. Stromme, who is also based in Europe, assumes the responsibilities of Chair of the Board. Mr. Stromme has been a Director of the Company since July 2020 and has deep expertise in strategy, transformational change, M&A, Capital Markets and early-stage technology ventures. The current Chair, Mr. Humphrey Nolan, will continue to serve as a Non-Executive Director of the Company. Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.065 loss per share (vs AU$0.09 loss in FY 2022) Full year 2023 results: AU$0.065 loss per share (improved from AU$0.09 loss in FY 2022). Revenue: AU$4.45m (down 16% from FY 2022). Net loss: AU$14.4m (loss narrowed 15% from FY 2022). New Risk • Aug 30
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$13m free cash flow). Share price has been highly volatile over the past 3 months (27% average weekly change). Earnings have declined by 31% per year over the past 5 years. Shareholders have been substantially diluted in the past year (323% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Revenue is less than US$5m (AU$5.8m revenue, or US$3.8m). Market cap is less than US$100m (AU$17.3m market cap, or US$11.2m). Ankündigung • Aug 25
Titomic Limited to Report Fiscal Year 2023 Results on Aug 31, 2023 Titomic Limited announced that they will report fiscal year 2023 results on Aug 31, 2023 New Risk • Jun 29
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 95% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$13m free cash flow). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 31% per year over the past 5 years. Shareholders have been substantially diluted in the past year (95% increase in shares outstanding). Market cap is less than US$10m (AU$8.67m market cap, or US$5.75m). Minor Risk Revenue is less than US$5m (AU$5.8m revenue, or US$3.8m). New Risk • Jun 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$13m free cash flow). Earnings have declined by 31% per year over the past 5 years. Market cap is less than US$10m (AU$12.7m market cap, or US$8.46m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Revenue is less than US$5m (AU$5.8m revenue, or US$3.9m). Breakeven Date Change • Apr 01
Forecast to breakeven in 2025 The analyst covering Titomic expects the company to break even for the first time. New forecast suggests losses will reduce by 52% per year to 2024. The company is expected to make a profit of AU$5.90m in 2025. Average annual earnings growth of 94% is required to achieve expected profit on schedule. Reported Earnings • Mar 03
First half 2023 earnings released: AU$0.035 loss per share (vs AU$0.045 loss in 1H 2022) First half 2023 results: AU$0.035 loss per share (improved from AU$0.045 loss in 1H 2022). Revenue: AU$2.79m (up 21% from 1H 2022). Net loss: AU$7.24m (loss narrowed 3.6% from 1H 2022). Revenue is forecast to grow 69% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings. Ankündigung • Feb 20
Titomic Limited to Report First Half, 2023 Results on Feb 28, 2023 Titomic Limited announced that they will report first half, 2023 results on Feb 28, 2023 Ankündigung • Nov 21
Titomic Limited Announces Jeffrey Lang Retired as A Non-Executive Director Titomic Limited announced that Jeffrey Lang has retired as a Non-Executive Director of the Company at the conclusion of Annual General Meeting. Ankündigung • Nov 18
Titomic Limited Launches New D623 System Titomic Limited announced it has developed a new product; the Titomic D623 medium-pressure cold spray System ("System" or "D623"). The new D623 further extends Titomic's product line, enhancing Titomic's commercial offering and providing further product options to key prospective customers to meet their varying needs. With this addition, Titomic now offers a leading range of cold spray systems, helping the Company to be cemented as a category leader. The D623 is capable of depositing harder metals compared to the D523, enhancing the System's key capabilities such as wear-resistant coatings and restoration of high-wear parts, among other additional product innovations. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. MD & Executive Director Herbert Koeck was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Oct 28
High number of new directors There are 5 new directors who have joined the board in the last 3 years. MD & Executive Director Herbert Koeck was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Oct 22
Titomic Limited, Annual General Meeting, Nov 21, 2022 Titomic Limited, Annual General Meeting, Nov 21, 2022, at 14:00 AUS Eastern Standard Time. Location: 365 Ferntree Gully Road Mount Waverley Victoria Australia Agenda: To discuss the 2022 annual financial statements; to consider the adoption of 2022 remuneration report; to consider the re-election of Mr Richard Willson; to consider the re-election of Dr Andreas Schwer; to consider the election of Mr Herbert Koeck; to consider the renewal of approval of Equity Incentive Plan; and to consider the approval of additional capacity to issue securities under ASX Listing Rule 7.1A. Ankündigung • Oct 17
Titomic Limited Receives A CoBRAIN Grant for its Titomic Europe Division as Part of the European Union's Horizon Europe Initiative Titomic Limited has been awarded a CoBRAIN grant for its Titomic Europe division as part of the European Union's (EU) Horizon Europe initiative. Titomic will receive €260,000 (~AUD 400,000) in CoBRAIN funding, to research and develop applications of artificial intelligence and machine learning within cold spray applications. The outcomes of the research will assist Titomic in optimising cold spray processes for manufacturing with new and existing materials and metals. The CoBRAIN program will develop novel hard metals for corrosion and wear resistance and validate an integrated computational-experimental material engineering workflow. Ultimately, the grant funding will further assist Titomic in undertaking research and development to further heighten Titomic's technological competitive edge. The first tranche of funding is expected to be received in fiscal year 2023. This grant comes after recent success Titomic had with the International Partners in Glass Research (IPGR) network, developing and selling a system for the coating of glass moulds that is a breakthrough in automated cold spray by using artificial intelligence to enhance productivity and mitigate operating costs. Titomic hopes to replicate this product development success with CoBRAIN. Price Target Changed • Oct 05
Price target decreased to AU$0.54 Down from AU$0.75, the current price target is an average from 2 analysts. New target price is 133% above last closing price of AU$0.23. Stock is down 29% over the past year. The company is forecast to post a net loss per share of AU$0.05 next year compared to a net loss per share of AU$0.09 last year. Reported Earnings • Oct 02
Full year 2022 earnings released: AU$0.09 loss per share (vs AU$0.11 loss in FY 2021) Full year 2022 results: AU$0.09 loss per share (improved from AU$0.11 loss in FY 2021). Revenue: AU$5.32m (up 168% from FY 2021). Net loss: AU$17.0m (loss narrowed 1.2% from FY 2021). Revenue is forecast to grow 55% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has fallen by 46% per year, which means it is performing significantly worse than earnings. Breakeven Date Change • Sep 01
No longer forecast to breakeven The analyst covering Titomic no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of AU$1.20m in 2024. New forecast suggests the company will make a loss of AU$9.50m in 2024. Ankündigung • Aug 23
Titomic Limited to Report Fiscal Year 2022 Results on Aug 31, 2022 Titomic Limited announced that they will report fiscal year 2022 results on Aug 31, 2022 Breakeven Date Change • Jul 06
No longer forecast to breakeven The analyst covering Titomic no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of AU$1.20m in 2024. New forecast suggests the company will make a loss of AU$9.50m in 2024. Ankündigung • Apr 26
Titomic Limited Announces Senior Management Appointments Titomic Limited announced the appointment of Mr. Neil Matthews and Mr. Bruce Colter who will both commence employment with Titomic on 2nd May. Neil Matthews has extensive experience in the Cold Spray Industry and will be joining Titomic as Head of Business Development - Repairs. Bruce Colter also has substantial Cold Spray experience and is joining Titomic as General Manager - Titomic USA. Ankündigung • Apr 01
Titomic Limited Announces Resignation of Jeffrey Lang as Chief Technology Officer and as an Executive Director Titomic Limited announced that Jeffrey Lang has resigned as its Chief Technology Officer and is retiring as an Executive Director to pursue other opportunities. Jeff will remain a Non-Executive Director of Titomic until the AGM later this year, but has decided not to stand for re-election to the Board at that time. Ankündigung • Mar 28
Titomic Limited Announces Executive Changes Titomic Limited advised that Mr. Chris Healy, the Company's internal Legal Counsel, has been appointed as Titomic's Company Secretary replacing Mr. Richard Willson who remains a Non-Executive Director. Breakeven Date Change • Mar 01
Forecast breakeven date pushed back to 2024 The analyst covering Titomic previously expected the company to break even in 2023. New forecast suggests losses will reduce by 40% per year to 2023. The company is expected to make a profit of AU$1.20m in 2024. Average annual earnings growth of 79% is required to achieve expected profit on schedule. Ankündigung • Feb 25
Titomic Limited to Report First Half, 2022 Results on Feb 28, 2022 Titomic Limited announced that they will report first half, 2022 results on Feb 28, 2022 Ankündigung • Jan 29
Titomic Limited Announces Board Changes Titomic Limited appointed Mr. Herbert Koeck, Titomic's Chief Executive Officer, has been appointed Managing Director of the Company. Mr. Koeck's elevation underlines the board's confidence in his leadership, as well as his demonstrated ability to implement the company's commercialization strategy. Due to increasing commitments outside of Titomic, Mr. Andreas Schwer has advised the Company's Board that he is stepping down as Chairman. The Board is pleased that Mr. Schwer will continue as a Non-Executive Director. The Board has elected Mr. Humphrey Nolan, a Sydney-based Director of the Company since July 2020, as Chairman. Ankündigung • Dec 01
Titomic Limited (ASX:TTT) acquired Dycomet Europe B.V. for €1.5 million. Titomic Limited (ASX:TTT) acquired Dycomet Europe B.V. for €1.5 million on November 30, 2021. As per the transaction, Titomic Limited will pay cash consideration of €1.3 million from which €1 million paid on completion and two equal deferred payments of €0.15m being paid 18 months and 36 months after completion. Also, the vendors will be issued 1.5 million ordinary shares in Titomic Limited in three equal tranches on the first, second and third anniversaries of completion. As a part of the transaction, Dycomet’s Founder and Chief Executive Officer, Klaas Rozema and his team will join Titomic Limited with Klaas Rozema, stepping into the new role of General Manager of Titomic Europe.
Titomic Limited (ASX:TTT) completed the acquisition of Dycomet Europe B.V. on November 30, 2021. Reported Earnings • Aug 31
Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.081 loss in FY 2020) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: AU$1.98m (down 1.1% from FY 2020). Net loss: AU$17.2m (loss widened 59% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has fallen by 44% per year, which means it is performing significantly worse than earnings. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze was replaced as CEO by Herbert Koeck after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze was replaced as CEO by Herbert Koeck after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 04
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 03
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 03
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Executive Departure • Jul 03
Interim Chief Executive Officer Norbert Schulze has left the company During their tenure, earnings grew by 43% annually compared to the industry average, which went down by 46%. On the 1st of July, Norbert Schulze left the company after less than a year in the role. We don't have any record of a personal shareholding under Norbert's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Norbert's leadership, the company delivered a total shareholder return of -29%. Recent Insider Transactions • May 30
Independent Non-Executive Chairman recently bought AU$50k worth of stock On the 25th of May, Andreas Schwer bought around 100k shares on-market at roughly AU$0.50 per share. In the last 3 months, there was an even bigger purchase from another insider worth AU$81k. This was Andreas' only on-market trade for the last 12 months. Ankündigung • Mar 15
Titomic Limited and Shree Rapid Technologies to Grow the Additive Manufacturing Market in India Titomic Limited announced it has entered into a relationship with the India- The two companies have signed an agreement whereby SRT will use its extensive sales and marketing reach as well as industry and market expertise in India to promote Titomic's TKF technology. SRT's agreement with Titomic will enable products manufactured with TKF technology to meet stringent military requirements, including performance in temperature extremes, robustness, and durability under very demanding operating environments. It will fill an important performance gap in the Indian additive manufacturing sector overcoming the current 3D printing production process and materials limitations. Reported Earnings • Mar 03
First half 2021 earnings released: AU$0.052 loss per share (vs AU$0.037 loss in 1H 2020) First half 2021 results: Net loss: AU$6.96m (loss widened 48% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Ankündigung • Feb 27
Tawazun Strategic Development Fund Llc and Titomic Ltd Sign Mou to Collaborate Towards Setting Up an Advanced Industrial Scale 3D Printing Manufacturing Facility in the United Arab Emirates Tawazun and Australian company TITOMIC have signed an MOU to assess the potential of setting up a joint venture between the parties to establish a local manufacturing line in order to produce advanced 3D printing technologies for large products and components at industrial scale for a variety of industries mainly focusing on aerospace, defence oil and gas and mining in UAE. TITOMIC is an Australian listed public company that utilises patented additive manufacturing (3D Printing) technology with a reduced carbon footprint, robotic automation, Industry 4.0, and specialty materials expertise to create high-performance products and solves complex engineering challenges. The advanced technology additive manufacturing (3D Printing) plant will employ next-generation Industry 4.0 methods and industrial-scale automated production using high-performance metal alloys, including titanium, for a variety of industry applications. The potential joint venture between the parties will provide industrial scale 3D printing capability for the region. In addition, the 3D printing and manufacturing plant would also act as the distributor and after sale services center for TITOMIC products. The MOU was signed by Dr Andreas Schwer, Chairman of TITOMIC Limited, and Mohamed Musabah Al Mazrouei - Director, Ventures Investments, SDF. Strategic Development Fund (SDF), the investment arm of Tawazun Economic Council, is focused on financial return and economic impact within UAE’s strategic sectors, through equity investment in local and international partnerships and developmental funding towards UAE’s private sector. Ankündigung • Feb 16
Titomic Limited Announces Executive Changes Titomic Limited announced that Non-Executive Director Mr. Richard Willson has been appointed as Titomic's Company Secretary replacing Mr. Peter Vaughan. Titomic and its Board wish to thank Mr. Vaughan for his significant contribution to the Company as Company Secretary over the past 4 years and are pleased to advise he will be continuing with Titomic in a new role within the senior management team. Is New 90 Day High Low • Feb 15
New 90-day high: AU$0.65 The company is up 8.0% from its price of AU$0.60 on 17 November 2020. The Australian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Ankündigung • Dec 23
Titomic Limited, Annual General Meeting, Jan 28, 2021 Titomic Limited, Annual General Meeting, Jan 28, 2021, at 16:00 AUS Eastern Standard Time. Agenda: To receive and consider the Annual Financial Report of the Company for the financial year ended 30 June 2020 together with the Remuneration Report, Director's Declaration and the reports of the Directors and company Auditor; to consider adoption of 2020 Remuneration Report; to consider election of Non-Executive Director Dr Andreas Schwer; to consider election of Non-Executive Director Mr Dag W.R. Stromme; to consider election of Non-Executive Director Mr Humphrey Nolan; to consider ratification of prior issue of Shares to investors; to consider ratification of prior issue of Options to Evans & Partners; to consider ratification of prior issue of options to Composite Technology; to consider approval of issue of options to Evans & Partners; to consider approval of issue of options to Composite Technology; and to consider approval of issue of performance share rights. Is New 90 Day High Low • Dec 15
New 90-day low: AU$0.52 The company is down 25% from its price of AU$0.69 on 16 September 2020. The Australian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 1.0% over the same period. 
